Enhanced sensitivity of tumor necrosis factor/lymphotoxin-α-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-γ and interleukin-12

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1637-1647

  Rayhane, Naïma ^c   Lortholary, Olivier ^c   Fitting, Catherine ^c   Callebert, Jacques ^a   Huerre, Michel ^c   Dromer, Françoise ^c   Cavaillon, Jean Marc ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUT PASTEUR   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; NITRITE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; TISSUE LEVEL;

ANIMALS; BRAIN; CHEMOKINES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOTOXIN-ALPHA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRATES; NITRITES; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0005533254     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315061     Document Type: Article

References (49)

1. 1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993;17: 837-42.
2. 2. Kawakami K, Qifeng X, Tohyama M, Qureshi MH, Saito A. Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans. Clin Exp Immunol 1996;106:468-74.
3. 3. Joly V, Saint-Julien L, Carbon C, Yeni P. In vivo activity of interferon-γ in combination with amphotericin B in the treatment of experimental cryptococcosis. J Infect Dis 1994;170:1331-4.
4. 4. Kawakami K, Tohyama M, Xie Q, Saito A. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996;104:208-14.
5. γ production. J Immunol 1997;159:5528-34.
6. 6. Zhang TT, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 1997;65:3594-9.
7. 7. Chen GH, Curtis JL, Mody CH, Christensen PJ, Armstrong LR, Toews GB. Effect of GM-CSF on rat alveolar macrophage anti-cryptococcal activity in vitro. J Immunol 1994;152:724-34.
8. 8. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994;62:1975-81.
9. 9. Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992;22:1447-54.
10. 10. Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995;63: 1725-31.
11. 11. Huffnagle GB, Toews GB, Burdick MD, et al. Afferent phase production of TNF-alpna is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996;157:4529-36.
12. γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997;17:733-9.
13. + T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995;155:4790-7.
14. 14. Huffnagle GB, Strieter RM, McNeil LK, et al. Macrophage inflammatory protein-1α (MIP-1α) is required for the afferent phase of pulmonary cell-mediated immunity to a Cryptococcus neuformans infection. J Immunol 1997;159:318-27.
15. 15. Cross CE, Collins HL, Bancroft GJ. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology 1997;91:289-96.
16. 16. Zhong Z, Pirofski LA. Antifungal activity of a human antiglucuronoxylomannan antibody. Clin Diagn Lab Immunol 1998;5:58-64.
17. 17. Kozel TR. Activation of the complement system by pathogenic fungi. Clin Mirobiol Rev 1996;9:34-46.
18. 18. Chaka W, Verheul A, Vaishnav VV, et al. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun 1997;65:272-8.
19. 19. Vecchiarelli A, Retini C, Casadevall A, Monari C, Pietrella D, Kozet TR. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans. Infect Immun 1998;66:4324-30.
20. 20. Yuan R, Casadevall A, Oh J, Scharff M. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci USA 1997;94:2483-8.
21. 21. Decken K, Köhler G, Palmer-Lehmann K, et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 1998;66:4994-5000.
22. 22. Amíot F, Boussadia O, Cases S, et al. Mice heterozygous for a deletion of the TNFα and LTα genes: biological importance of a nonlinear response of TNFα dosage. Eur J Immunol 1997;27:1035-42.
23. 23. Amiot F, Fitting C, Tracey KJ, Cavaillon JM, Dautry F. LPS-induced cytokine cascade and lethality in LTα/TNFα deficient mice. Mol Med 1997;3:864-75.
24. 24. Lee SC, Dickson DW, Brosnan CF, Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994;180:365-9.
25. 25. Dromer F, Charreire J. Improved amphotericin B activity by a monoclonal anti Cryptococcus neoformans antibody. J Infect Dis 1991;163:1114-20.
26. 26. Lortholary O, Improvisi L, Nicolas M, Provost F, Dupont B, Dromer F. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med Mycol 1999;37:169-74.
27. 27. Giovannoni G, Land JM, Keir G, Thompson EJ, Heales SJR. Adaptation or nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem 1997;34:193-8.
28. 28. Vecchiarelli A, Retini C, Munari C, Tascini C, Bistoni F, Kozel TR. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996;64:2846-9.
29. 29. Levitz SM, North EA. Gamma interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect Immun 1996;64:1595-9.
30. 30. Retini C, Vecchiarelli A, Monari C, Tascini C, Bistoni F, Kozel TR. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun 1996;64:2897-903.
31. 31. Lipovsky MM, Gekker G, Hu S, Ehrlich LC, Hoepelman AIM, Peterson PK. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J Infect Dis 1998;177:260-3.
32. 32. Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995;63:2604-11.
33. 33. Li RK, Mitchell TG. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcuss neoformans and anti C. neoformans antiserum. J Med Vet Mycol 1997;35:327-34.
34. 34. Huffnagle GB. Role of cytokines in T cell immunity to a pulmonary Cryptococcus neoformans infection. Biol Signals 1996;5:215-22.
35. 35. Kawakami K, Tohyama M, Qifeng X, Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun 1997; 65:1307-12.
36. 36. Blasi E, Barluzzi R, Mazzolla R, et al. Biomolecular events involved in anticryptococcal resistance in the brain. Infect Immun 1995;63:1218-22.
37. 37. Barluzzi R, Mazolla R, Brozzetti A, et al. A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: charatterization of the local immune reaction by RT-PCR and histothemical analysis. J Neuroimmunol 1997;79:37-48.
38. 38. Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-67.
39. 39. Rothe J, Lesslauer W, Löscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364:798-802.
40. 40. Nashleanas M, Kanaly S, Scott P. Control of Leishmania major infection in mice lacking TNF receptors. J Immunol 1998;160:5506-13.
41. 41. Eugster HP, Muller M, Karrer U, et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol 1996;8:23-6.
42. 42. Steinshamn S, Bemelmans MHA, van Tits LJ, Bergh K, Buurman WA, Waage A. TNF receptors in murine Candida albicans infection. Evidence for an important role of TNF receptor p55 in antifungal defense. J Immunol 1996;157:2155-9.
43. 43. Mencacci A, Cenci E, Del Sero G, et al. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-α double deficient mice infected with Candida albicans. Int Immunol 1998;10:37-48.
44. 44. Rudin W, Eugster HP, Bordmann G, et al. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol 1997;150:257-66.
45. 45. Huffnagle GB, McNeil LK. Dissemination of C. neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment. J Neurovirol 1999;5:76-81.
46. 46. Levitz SM, Tabuni A, Nong SH, Golenbock DT. Effetts of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect Immun 1996;64:945-51.
47. 47. Monari C, Retini C, Palazzetti B, Bistoni F, Vecchiarelli A. Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans. Clin Exp Immunol 1997;109:242-7.
48. 48. Huang FP, Xu D, Esfandiari EO, Sands W, Wei XQ, Liew FY. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses and enhanced nitric oxide production. J Immunol 1998;160:4143-7.
49. 49. Amiot F, Bellkaid Y, Lebastard M, Ave P, Dautry F, Milon G. Abnormal organisation of the splenic marginal zone and the correlated leukocytosis in lymphotoxin-α and tumor necrosis factors double deficient mice. Eur Cytokine Netw 1996;7:733-9.